Article info

PDF

Original article
Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2

Authors

  1. Correspondence to Professor Philip J Mease; pmease{at}philipmease.com
View Full Text

Citation

Van den Bosch F, Mease PJ, Sieper J, et al
Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2

Publication history

  • Received August 25, 2017
  • Revision received December 21, 2017
  • Accepted January 9, 2018
  • First published February 26, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.